イントラテカルミトザントロン投与後のパラプレジー.

Rodent home cage monitoring for preclinical safety pharmacology assessment: results of a multi-company validation evaluating nonclinical and clinical data from three compounds.

Frontiers in toxicology·2025

Cereal grain mineral micronutrient and soil chemistry data from GeoNutrition surveys in Ethiopia and Malawi.

Scientific data·2022

Cervical musculoskeletal and sensorimotor impairments 4 weeks to 6 months following mild traumatic brain injury: An observational cohort study.

Musculoskeletal science & practice·2021

Change in a clinical measure of cervical movement sense following four weeks of kinematic training.

Musculoskeletal science & practice·2020

Can a simple clinical test demonstrate head-trunk coordination impairment in neck pain?

Musculoskeletal science & practice·2020

Establishing a baseline for a national paediatric antimicrobial stewardship programme.

The Journal of antimicrobial chemotherapy·2019

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Biotechnology and bioengineering·2026

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Nucleic acids research·2026

Case Report: Novel homozygous pathogenic variant of the <i>SPG20</i> gene causes the Troyer syndrome in China.

Frontiers in genetics·2026

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Extracellular vesicles and circulating nucleic acids·2026

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Frontiers in immunology·2026

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

The Journal of clinical and aesthetic dermatology·2026

関連する実験動画

イントラテカルミトザントロン投与後のパラプレジー.

関連する概念動画

Rodent home cage monitoring for preclinical safety pharmacology assessment: results of a multi-company validation evaluating nonclinical and clinical data from three compounds.

Cereal grain mineral micronutrient and soil chemistry data from GeoNutrition surveys in Ethiopia and Malawi.

Cervical musculoskeletal and sensorimotor impairments 4 weeks to 6 months following mild traumatic brain injury: An observational cohort study.

Change in a clinical measure of cervical movement sense following four weeks of kinematic training.

Can a simple clinical test demonstrate head-trunk coordination impairment in neck pain?

Establishing a baseline for a national paediatric antimicrobial stewardship programme.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Case Report: Novel homozygous pathogenic variant of the <i>SPG20</i> gene causes the Troyer syndrome in China.

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

関連する実験動画

イントラテカルミトザントロン投与後のパラプレジー.

関連する概念動画

関連記事